Welcome to our dedicated page for Salesforce Com SEC filings (Ticker: CRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Salesforce, Inc. filings document the regulatory record of a New York Stock Exchange-listed enterprise software company. Recent 8-K reports cover operating and financial results, Regulation FD disclosures, material definitive agreements, accelerated share repurchase activity, senior note issuances and borrowings connected with acquisition financing.
Salesforce proxy and governance filings cover shareholder voting matters, board and executive compensation disclosures, officer-role changes and equity compensation topics. The filing record also describes capital-structure matters affecting common stock, debt securities, credit agreements and completed acquisition-related obligations.
Miguel Milano, President and Chief Revenue Officer of Salesforce, Inc. (CRM), reported transactions on 08/22/2025. Restricted stock units (RSUs) vested and converted one-for-one into 1,663 shares that were reported as acquired. To satisfy tax withholding upon settlement, 690 shares were withheld (reported as disposed) at a reported price of $248.29 per share. After these transactions the filings show beneficial ownership levels reported as 13,301 shares (derivative/total beneficial ownership) and 10,906 shares (direct beneficial ownership) in different table lines; the form does not provide additional context on total outstanding holdings beyond these reported figures.
Maynard G. Webb Jr., a Salesforce (CRM) director, reported insider transactions on Form 4 dated 08/22/2025. The filing shows 274 shares of common stock were acquired through vesting of 274 restricted stock units at no cash exercise price, increasing his direct beneficial ownership to 2,516 shares. The filing also reports 187 shares held indirectly via the Webb Family Trust.
The restricted stock units vest in four equal tranches: 25% on each of February 22, May 22, August 22, and November 22, 2025. The Form 4 was signed by Sarah Dale as attorney-in-fact for Mr. Webb on 08/25/2025.
John V. Roos, a Salesforce (CRM) director, reported the receipt of equity from previously granted restricted stock units that converted into common shares. On 08/22/2025, 274 restricted stock units vested and converted one-for-one into 274 shares of common stock at no cash price, and the filing shows 15,690 shares beneficially owned by Roos following the reported non-derivative transactions. The Form 4 was signed by an attorney-in-fact on 08/25/2025. Vesting schedule disclosed indicates the original RSU grant vested in quarterly 25% tranches on 02/22/2025, 05/22/2025, 08/22/2025 and 11/22/2025.
Oscar Muñoz, a director of Salesforce, Inc. (CRM), received 274 shares through vesting of restricted stock units on 08/22/2025. The transaction is reported on a Form 4 filed by one reporting person and shows 274 shares beneficially owned following the transaction in a direct ownership form. The filing explains the RSUs convert one-for-one to common stock and that these units vest quarterly with specific vesting dates in 2025.
Sachin J. Mehra, a director of Salesforce, Inc. (CRM), reported transactions on Form 4 showing 274 restricted stock units converted to 274 shares of common stock on 08/22/2025 at no cash price. The transaction is recorded as a vesting event (transaction code M) and increased Mr. Mehra's direct beneficial ownership to 3,807 shares following the reported transaction. The restricted stock units convert one-for-one to common shares and vest in four equal tranches: 25% on each of February 22, May 22, August 22, and November 22, 2025. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Mehra on 08/25/2025.
Neelie Kroes, a Salesforce (CRM) director, reported equity activity on 08/22/2025. She received 274 restricted stock units (RSUs) that convert one-for-one into common shares; those RSUs vest in four equal installments with the final noted vesting dates in 2025. To satisfy tax withholding on the award, 274 shares were treated as acquired then withheld (transaction code M) and converted to common stock at $0 for reporting purposes. Additionally, 42 shares were disposed of at $248.29, leaving Kroes with 11,002 total shares beneficially owned after the transactions.
Salesforce director David B. Kirk reported the vesting and conversion of restricted stock units into common shares on 08/22/2025. According to the filing, 424 restricted stock units vested and converted one-for-one into 424 shares of common stock at no cash price. After the reported transaction, the reporting person beneficially owned 424 shares directly and 4,493 shares indirectly through a trust. The filing is signed by an attorney-in-fact on behalf of the reporting person.
Insider report: Donald Arnold W, a Salesforce (CRM) director, reported transactions on 08/22/2025. He acquired 274 shares through conversion of restricted stock units that vested and were issued at no cash cost, and he disposed of 161 shares the same date. After the reported transactions he beneficially owns 4,257 shares indirectly through the Arnold W. Donald Rev Trust. The filing was submitted on 08/25/2025 and signed by an attorney-in-fact.
Craig Conway, a director of Salesforce, Inc. (CRM), reported the acquisition of 274 shares of common stock on 08/22/2025. The Form 4 shows the shares resulted from the vesting of 274 restricted stock units (RSUs) that convert one-for-one to common stock and carried a $0 purchase price. The reporting person held 8,338 shares of common stock following the transaction. The filing was signed by an attorney-in-fact on 08/25/2025 and lists the standard RSU vesting schedule showing quarterly vesting dates including 02/22/2025 through 11/22/2025.
Amy Chang, a Salesforce (CRM) director, reported receipt of 424 restricted stock units (RSUs) that convert one-for-one to common stock. The Form 4 shows a grant dated 08/22/2025 with transaction code "M" indicating acquisition under a Rule 16b-3 exemption. The RSUs vest 50% on 08/22/2025 and 50% on 11/22/2025, converting to 424 shares of common stock; the reported acquisition price is $0, consistent with typical equity awards to insiders. The filing was signed by an attorney-in-fact on 08/25/2025.